Open Access

Improvement of bone defect healing in rats via mesenchymal stem cell supernatant

  • Authors:
    • Wanshan Zhou
    • Qian Liu
    • Bo Xu
  • View Affiliations

  • Published online on: November 21, 2017     https://doi.org/10.3892/etm.2017.5534
  • Pages:1500-1504
  • Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By: 0 citations

Abstract

The effects of mesenchymal stem cells (MSCs) from three different sources in the treatment of bone defect with stem cells, and the differences of curative effects were studied. The umbilical cord, adipose and bone marrow mesen-chymal stem cells (BMSCs) of Sprague-Dawley (SD) rats were isolated and extracted, and the phenotype was identified for the 4th generation. The SD rat model of bone defect was established. The rats were randomly divided into: Normal saline group, umbilical cord mesenchymal stem cell (UMSC) group, adipose mesenchymal stem cell (AMSC) group and BMSC group. Rats were treated with tail intravenous injection, followed by radiological examination. The relative expression levels of factors bone morphogenetic protein-2 (BMP-2), osteocalcin (OCN), alkaline phosphatase (ALP), sclerostin (SOST), collagen carboxy-terminal telopeptide (CTX) and tartrated resistant acid phosphatase (TRACP) were measured via fluorescence quantitative PCR and western blotting. Among the three different kinds of stem cell supernatant, the detection using bicinchoninic acid (BCA) method showed that the content of P4-generation new cytokines was the highest. Wound healing in the three stem cell supernatant groups was significant at 3 weeks after operation, which was faster than that in DF12 control group; the expression levels of BMP-2, OCN and ALP in the bone samples treated with three kinds of MSC supernatants after 5 weeks were significantly increased compared with those in control group. The expression levels of SOST, CTX and TRACP were significantly decreased compared with those in control group. Three kinds of MSC supernatants can promote the bone regeneration through promoting the secretion of relatively more osteoblast factors, and inhibit the bone loss. The concentration of cytokines in UMSC supernatant was the highest under the same culture condition, and BMSC supernatant has a better effect in improving the bone defect repair of rats under the same concentration of cytokines.

Related Articles

Journal Cover

February 2018
Volume 15 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

2016 Impact Factor: 1.261
Ranked #50/128 Medicine Research and Experimental
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhou, W., Liu, Q., & Xu, B. (2018). Improvement of bone defect healing in rats via mesenchymal stem cell supernatant. Experimental and Therapeutic Medicine, 15, 1500-1504. https://doi.org/10.3892/etm.2017.5534
MLA
Zhou, W., Liu, Q., Xu, B."Improvement of bone defect healing in rats via mesenchymal stem cell supernatant". Experimental and Therapeutic Medicine 15.2 (2018): 1500-1504.
Chicago
Zhou, W., Liu, Q., Xu, B."Improvement of bone defect healing in rats via mesenchymal stem cell supernatant". Experimental and Therapeutic Medicine 15, no. 2 (2018): 1500-1504. https://doi.org/10.3892/etm.2017.5534